Library›Substances and pharmacology›The 2C Series and Extended Phenethylamines

The 2C Series and Extended Phenethylamines

The 2C Series and Extended Phenethylamines provides an exhaustive chemical, pharmacological, and historical reference on Alexander Shulgin's ring-substituted 2,5-dimethoxyphenethylamines (the 2C Family), their conformationally locked benzodifuran derivatives (FLY and DragonFLY), their $N$-benzyl super-agonists (NBOMes), and their 3-carbon amphetamine counterparts (the DOx Series).

Synthesized and systematically documented in Shulgin's 1991 masterwork PIHKAL (Phenethylamines I Have Known And Loved), the 2C series demonstrated that the 4-position of the phenethylamine aromatic ring represents a "magic window"—an infinitely tunable receptor-binding domain where subtle alterations in steric volume, lipophilicity, and halogenation radically alter potency, duration, and sensory texture.

The structural architecture: What is "2C"?

The designation "2C" is Alexander Shulgin's acronym denoting the two carbons separating the benzene ring from the primary amino group:

<code>

[ THE 2C GENERAL CHEMICAL SCAFFOLD ]

OCH3 (2-Position)

┌──┴──┐

│ O │── CH2─CH2─NH2 (2 Carbon Sidechain)

└──┬──┘

R (4-Position Variable Substituent)

OCH3 (5-Position)

</code>

The Fixed Core: All 2C compounds share a central benzene ring substituted with methoxy groups ($-OCH_3$) at the 2- and 5-positions. This 2,5-dimethoxy architecture establishes an optimal electronic dipole that fits into the orthosteric binding pocket of the human serotonin $5\text{-HT}_{2A}$ and $5\text{-HT}_{2C}$ receptors.
The 4-Position "Magic Window": The substituent ($R$) anchored to the 4-position faces directly into a deep lipophilic sub-pocket within the transmembrane core of the receptor. Altering $R$ (from halogens to alkyl chains to sulfur ethers) modulates affinity from millimolar down to low nanomolar ranges.

The classical core 2C family

Shulgin synthesized dozens of 2C analogues; the following compounds represent the core historical and pharmacological suite:

{| class="wikitable"

! Compound !! 4-Position ($R$) !! Typical Dose !! Active Duration !! Pharmacological & Phenomenological Profile

| 2C-B || Bromo ($-Br$) || 12–24 mg || 4–8 hours || Shulgin's favorite discovery; synthesized in 1974. Warm, empathogenic-psychedelic, rich visual geometry, tactile and erotic enhancement.

| 2C-C || Chloro ($-Cl$) || 20–40 mg || 4–8 hours || Mildest and most relaxing of the halogenated series; pronounced tranquil and sedative undertones.

| 2C-D || Methyl ($-CH_3$) || 20–60 mg || 4–6 hours || Shulgin termed it "pharmacological tofu"—subtle and undemanding alone, but remarkably amplifies and broadens other psychedelics when co-administered.

| 2C-E || Ethyl ($-CH_2CH_3$) || 10–20 mg || 8–12 hours || "The Teacher." Deep, intense, intellectually demanding, profound audio-visual synesthesia; very low physical toxicity but heavy cognitive load.

| 2C-I || Iodo ($-I$) || 12–24 mg || 6–10 hours || Bright, energetic, stimulating visual psychedelic; widely popular in the 2000s; precursor core for the NBOMe series.

| 2C-N || Nitro ($-NO_2$) || 100–150 mg || 4–6 hours || Unique brilliant yellow nitrate salt; rapid onset, intense somatic rushing, heavy physical body load.

| 2C-P || Propyl ($-CH_2CH_2CH_3$) || 6–10 mg || 14–18 hours || Exceptionally potent with a steep dose-response curve; slow onset (up to 2–3 hours) leading to dangerous accidental redosing.

| 2C-T-2 || Ethylthio ($-SCH_2CH_3$) || 12–25 mg || 6–10 hours || Warm, emotional, introspective; sulfur congener metabolized by FMO enzymes rather than CYP450.

| 2C-T-7 || Propylthio ($-S(CH_2)_2CH_3$) || 10–30 mg || 8–14 hours || "Blue Mystic." Brilliant visual architecture; lethal at high/insufflated doses due to intrinsic MAO-A inhibition interactions.

The Extended 2C Series: Rigid rings and super-agonists

Beyond simple aliphatic and halogen substitutions, medicinal chemists (most notably Dr. David E. Nichols and Ralf Heim) extended the 2C scaffold into conformationally restricted and ultra-high-affinity derivatives:

<code>

[ CONFORMATIONALLY RESTRICTED 2C VARIANTS ]

│

┌────────────────────────────┴────────────────────────────┐

▼ ▼

[ The FLY Family (e.g. 2C-B-FLY) ] [ The DragonFLY Family (e.g. Bromo-DragonFLY) ]

• Dihydrofuran rings fused at 2,5 positions • Fully aromatic difuran rings fused to ring

• Locks methoxy oxygens into rigid plane • Incorporates amphetamine α-methyl group

• Highly selective 5-HT2A agonist • Multi-day duration (30–48h); lethal vasoconstriction

</code>

1. The FLY and DragonFLY Families

In standard 2C molecules, the 2- and 5-methoxy groups can freely rotate around their carbon-oxygen bonds.
2C-B-FLY: Chemists cyclized the methoxy groups into saturated dihydrofuran rings fused to the central benzene core, locking the oxygen electron lone pairs into a rigid planar configuration. This conformational lock dramatically increases binding affinity at $5\text{-HT}_{2A}$, yielding an active dose of 10–15 mg.
Bromo-DragonFLY: Replaces the dihydrofuran rings with fully planar, fully aromatic furan rings and adds an $\alpha$-methyl group (making it an amphetamine).

** Bromo-DragonFLY is active at microgram doses ($500\text{–}1,000\,\mu\text{g}$).

** Toxicological Catastrophe: Due to extreme metabolic resistance, Bromo-DragonFLY has an active duration exceeding 30 to 48 hours. Its intense, unrelenting activation of peripheral vascular $5\text{-HT}_{2A}$ receptors induces severe, life-threatening vasoconstriction, leading to peripheral limb necrosis (gangrene requiring surgical amputation) and multiple documented fatalities.

2. The NBOMe and NBOH Transformation

In the early 2000s, Ralf Heim and David E. Nichols discovered that attaching an $N$-(2-methoxybenzyl) group to the primary amine of 2C molecules (e.g., adding an NBOMe group to 2C-I to create 25I-NBOMe) increases receptor binding affinity by several orders of magnitude:

: <code>2C-I (Ki ≈ 250 nM) ──► 25I-NBOMe (Ki ≈ 0.044 nM)   [~5,000x Increase in Affinity]</code>

This shifted phenethylamine dosing from milligrams down into the sub-milligram microgram range ($250\text{–}800\,\mu\text{g}$), creating dangerous counterfeit blotter risks.

3. Fluoroalkyl and exotic extensions

2C-EF (4-(2-fluoroethyl)): Highly potent and visual derivative combining the ethyl group of 2C-E with a terminal fluorine atom to block terminal hydroxylation.
2C-T-21 (4-(2-fluoroethylthio)): Fluorinated thioether derivative active at 8–12 mg.
2C-iP (4-isopropyl): Branched aliphatic derivative demonstrating that steric bulk at the 4-position reduces potency compared to linear chains.

The 2C vs. DOx Amphetamine Bridge

Every 2C phenethylamine possesses an exact 3-carbon amphetamine counterpart (the DOx family), created by adding a single methyl group to the $\alpha$-carbon of the side chain:

<code>

[ 2C Phenethylamine (2-Carbon Sidechain) ] [ DOx Amphetamine (3-Carbon Sidechain) ]

CH2─CH2─NH2 CH2─CH(CH3)─NH2

│ │

[ 2 Carbons ] [ 3 Carbons (α-Methyl) ]

• Rapid MAO Degradation • MAO Sterically Blocked

• Duration: 4–10 Hours • Duration: 14–30 Hours

• Milligram Doses (10–30 mg) • Microgram/Low-mg Doses (1–5 mg)

</code>

{| class="wikitable"

! 2C Phenethylamine (2-Carbon) !! DOx Amphetamine Counterpart (3-Carbon) !! 2C Duration !! DOx Duration !! DOx Potency

| 2C-B (4-Bromo) || DOB (Brolamfetamine) || 4–8 hours || 18–30 hours || 1.0–3.0 mg

| 2C-C (4-Chloro) || DOC || 4–8 hours || 12–20 hours || 1.5–3.5 mg

| 2C-D (4-Methyl) || DOM ("STP" / Serenity, Tranquility, Peace) || 4–6 hours || 14–20 hours || 3.0–10.0 mg

| 2C-I (4-Iodo) || DOI (Standard lab 5-HT2A probe) || 6–10 hours || 16–24 hours || 1.5–3.0 mg

| 2C-N (4-Nitro) || DON || 4–6 hours || 8–12 hours || 3.0–5.0 mg

| 2C-T-2 (4-Ethylthio) || Aleph-2 || 6–10 hours || 12–16 hours || 4.0–8.0 mg

| 2C-T-7 (4-Propylthio) || Aleph-7 || 8–14 hours || 16–24 hours || 4.0–7.0 mg

Why the $\alpha$-methyl group alters duration and potency

1. Steric Hindrance of MAO: Endogenous monoamine oxidase (MAO) enzymes rapidly deaminate unhindered primary phenethylamines (like the 2Cs), cleaving the amine into inactive phenylacetaldehydes. The $\alpha$-methyl group of the DOx series acts as a physical shield, sterically blocking MAO from docking to the amine.

2. Extended Half-Life: Because MAO cannot degrade the molecule, elimination depends entirely on slower Cytochrome P450 oxidation, multiplying the duration of action by a factor of three to four.

3. Elevated Cardiovascular Toxicity: The protracted duration maintains continuous peripheral $5\text{-HT}_{2A}$-mediated vasoconstriction and sympathetic stimulation for over 24 hours, significantly elevating the risk of hypertensive crises, hyperthermia, and acute renal stress compared to the self-limiting 2C series.

Pharmacology and Harm Reduction

1. Steep dose-response curves (The 2C-P trap)

While classic compounds like mescaline or psilocybin possess broad, forgiving dosage plateaus, high-potency phenethylamines (particularly **2C-E** and **2C-P**) exhibit steep, non-linear dose-response curves:

With 2C-P, taking 8 mg produces a manageable psychedelic experience, whereas taking 11 mg can trigger a terrifying, multi-day delirium with unmanageable tremors and cardiovascular emergencies.
Because powders vary wildly in bulk density, these compounds must never be eyeballed and require **Volumetric Liquid Dosing (VLD)**.

2. Reagent testing identification

The 2C series can be reliably screened and differentiated using colorimetric test kits:

Marquis: 2C-B flashes yellow and turns dark green; 2C-I turns yellow-brown; 2C-E flashes yellow and shifts to deep green/blue; 2C-T-7 turns orange/brown.
Mecke: Distinctive green-brown and yellow-brown chromophores.
Ehrlich Reagent: Produces **zero color change (remains clear)**, definitively proving the sample is not an indole/ergoline (ruling out LSD).

Filed under Substances and pharmacology Organic chemistry and synthesis